MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA to launch consultation on device international reliance plan by year’s end

The UK Medicines and Healthcare products Regulatory Agency (MHRA) plans to publish a public consultation on a proposal to allow medical devices automatic access...
Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Health Canada digital health head says AI/ML guidance imminent

Health Canada is very close to publishing a much-anticipated guidance on artificial intelligence/machine learning (AI/ML) medical devices and has incorporated pre-determined change control plans...
TÜV Rheinland Becomes 5th Notified Body Designated Under MDR

Europe – Commission Implementing Decision (EU) 2024/2625 of 8 October 2024 amending Implementing Decision...

THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 1025/2012 of the European Parliament and...
TÜV Rheinland Becomes 5th Notified Body Designated Under MDR

Europe – Commission Implementing Decision (EU) 2024/2631 of 8 October 2024 amending Implementing Decision...

THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 1025/2012 of the European Parliament and...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – MDCG 2024-11 Guidance on qualification of in vitro diagnostic medical devices

The purpose of this guidance document is to clarify what products fall in scope of Regulation 2017/746 on in vitro diagnostic medical devices (IVDR)...

India – Central Drugs Standard Control Organization (CDSCO) under Ministry of Health & Family...

The Ministry of Health and Family Welfare has introduced comprehensive regulations for medical devices aimed at aligning the country's regulatory framework with globally accepted...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – MDCG 2024-12 Corrective and preventive action (CAPA) plan assessment: guidance and templates...

This guidance document is intended for conformity assessment bodies (CABs), notified bodies (NBs), designating authorities (DAs), and Joint Assessment Teams (JATs) involved in Regulation (EU) 2017/745...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA e-cigarette and vape products regulator profile

The information below contains the contact details and responsibilities of each of the regulatory bodies involved in the regulation of e-cigarette and vape products...
HAS - Webinaire sur l'évaluation des dispositifs médicaux : visionnez le replay

France – La HAS réévalue les systèmes connectés de prise en charge du diabète

Saisie par le ministère chargé de la Santé, la Haute Autorité de santé (HAS) a réévalué les conditions de prise en charge par l’Assurance...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – An update on our plans for Med Tech regulatory change

Our external engagement on the programme of regulatory changes for medical devices has re-started in earnest this week following the pre-election period and early...

NOS PROCHAINES FORMATIONS